A comparative study between three stability indicating spectrophotometric methods for the determination of diatrizoate sodium in presence of its cytotoxic degradation product based on two-wavelength selection

Simple item page
dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorRiad S.M.
dc.contributor.authorEl-Rahman M.K.A.
dc.contributor.authorFawaz E.M.
dc.contributor.authorShehata M.A.
dc.contributor.otherAnalytical Chemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherCairo University
dc.contributor.otherKasr-El Aini Street
dc.contributor.otherCairo
dc.contributor.other11562
dc.contributor.otherEgypt; Analytical Chemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober for Modern Sciences and Arts University
dc.contributor.other6th of October City
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:41:48Z
dc.date.available2020-01-09T20:41:48Z
dc.date.issued2015
dc.descriptionScopus
dc.description.abstractAbstract Three sensitive, selective, and precise stability indicating spectrophotometric methods for the determination of the X-ray contrast agent, diatrizoate sodium (DTA) in the presence of its acidic degradation product (highly cytotoxic 3,5-diamino metabolite) and in pharmaceutical formulation, were developed and validated. The first method is ratio difference, the second one is the bivariate method, and the third one is the dual wavelength method. The calibration curves for the three proposed methods are linear over a concentration range of 2-24 ?g/mL. The selectivity of the proposed methods was tested using laboratory prepared mixtures. The proposed methods have been successfully applied to the analysis of DTA in pharmaceutical dosage forms without interference from other dosage form additives. The results were statistically compared with the official US pharmacopeial method. No significant difference for either accuracy or precision was observed. 2015 Elsevier B.V. All rights reserved.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=24530&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1016/j.saa.2015.03.030
dc.identifier.doiPubMed ID 25791882
dc.identifier.issn13861425
dc.identifier.otherhttps://doi.org/10.1016/j.saa.2015.03.030
dc.identifier.otherPubMed ID 25791882
dc.identifier.urihttps://t.ly/2dPx5
dc.language.isoEnglishen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesSpectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
dc.relation.ispartofseries145
dc.subjectOctober University for Modern Sciences and Arts
dc.subjectجامعة أكتوبر للعلوم الحديثة والآداب
dc.subjectUniversity of Modern Sciences and Arts
dc.subjectMSA University
dc.subjectBivariateen_US
dc.subjectDual wavelengthen_US
dc.subjectRatio differenceen_US
dc.subjectSodium diatrizoateen_US
dc.subjectStability indicating methodsen_US
dc.subjectDegradationen_US
dc.subjectPhotodegradationen_US
dc.subjectSodiumen_US
dc.subjectSpectrophotometersen_US
dc.subjectBivariateen_US
dc.subjectDiatrizoateen_US
dc.subjectDual wavelengthen_US
dc.subjectRatio differencesen_US
dc.subjectStability indicating methoden_US
dc.subjectSpectrophotometryen_US
dc.subjectdiatrizoateen_US
dc.subjectmeglumine diatrizoateen_US
dc.subjectcell deathen_US
dc.subjectchemistryen_US
dc.subjectcomparative studyen_US
dc.subjectdrug effectsen_US
dc.subjectlighten_US
dc.subjectproceduresen_US
dc.subjectreproducibilityen_US
dc.subjectspectrophotometryen_US
dc.subjectstandarden_US
dc.subjectCell Deathen_US
dc.subjectDiatrizoateen_US
dc.subjectDiatrizoate Meglumineen_US
dc.subjectLighten_US
dc.subjectReference Standardsen_US
dc.subjectReproducibility of Resultsen_US
dc.subjectSpectrophotometryen_US
dc.titleA comparative study between three stability indicating spectrophotometric methods for the determination of diatrizoate sodium in presence of its cytotoxic degradation product based on two-wavelength selectionen_US
dc.typeArticleen_US
dcterms.isReferencedByLotfy, H.M., Abosen, M.M.A.E.-M., El-Bardicy, M.G., (2010) Drug Test. Anal., 2 (4), pp. 188-199; Metwally, F.H., Abdelkawy, M., Abdelwahab, N.S., (2007) Spectrochim. Acta Part A, 68 (5), pp. 1220-1230; De Zan, M.M., Cmara, M.S., Robles, J.C., Kergaravat, S.V., Goicoechea, H.C., (2009) Talanta, 79 (3), pp. 762-767; Sweetman, S.C., (2010) Martindale: The Complete Drug Reference (36th edition)-contrast media, pp. 1327-1348; Christiansen, C., (2005) X-ray contrast media-an overview, pp. 185-187; Barrs, T.J., (2005) X-rays and radiopaque drugs, pp. 2026-2030; Katayama, H., Yamaguchi, K., Kozuka, T., Takjashima, T., Seez, P., Matsuura, K., (1990) J. Radiol., 175, pp. 621-662; El-Rahman, M.K.A., Riad, S.M., Gawad, S.A.A., Fawaz, E.M., Shehata, M.A., (2015) Spectrochim. Acta Part A, 136, pp. 1167-1174; Tan, S., Qisu, X., Chin, J., (1991) Pharm. Anal., 11 (3), pp. 184-185; Hanna, G.M., Lau-Cam, C.A., (1996) J. AOAC Int., 79 (4), pp. 833-838; Farag, S.A., Wells, C.E., (1997) Mikrochim. Acta, 126 (1-2), pp. 141-145; Farag, S.A., (1995) J. AOAC Int., 78 (2), pp. 328-333; Chellquist, E.M., Nelson, W.O., Storflor, H.L., (1997) J. Pharm. Biomed. Anal., 16 (1), pp. 39-45; The United States Pharmacopeia and National Formulary, (2011) The Official Compendia of Standards, 2, pp. 2531-2542. , Asian Edition, USP 34-NF 29 The United States Pharmacopeial Convention Inc., Rockvill, MD; Weiss, R., Hsu, B., Wheeler, L., Norman, A., Riley, R.F., (1981) Invest. Radiol., 16 (6), pp. 517-524; Elzanfaly, E.S., Saad, A.S., Abd Elaleem, A.E., (2012) J. Pharm. Anal., 2, pp. 382-385; Elzanfaly, E.S., Saad, A.S., Abd-Elaleem, A.E., (2012) Saudi Pharm. J., 20, pp. 249-253; Elzanfaly, E., Saad, A., Abd-Elaleem, A., (2012) Pharm. Anal. Acta, 3, pp. 153-156; Lotfy, H.M., Hegazy, M.A., (2013) Spectrochim. Acta, 113, pp. 107-114; Lotfy, H.M., Hegazy, M.A., (2012) Spectrochim. Acta, 96, pp. 259-270; Lopez-De-Alba, P., Lopez-Martinez, L., Wrobel-Kaczmarczyk, K., Wrobel-Zasada, K., Amador-Hermndez, J., (1996) Anal. Lett., 29, pp. 487-503; Massart, D., Vandeginste, B., Deming, S., Michotte, Y., Kaufman, L., (1988) Chemometrics: A Textbook, , Elsevier Amsterdam; Darwish, H.W., Hassan, S.A., Salem, M.Y., El-Zeany, B.A., (2013) Spectrochim. Acta Part A, 104, pp. 70-76; Abdelwahab, N.S., Singh, H.P., Sharma, C.S., Ankalgi, A.D., Agal, S.K., Ranawat, M.S., (2011) Arab. J. Chem., 1016, pp. 10-15; Singh, H.P., Sharma, C.S., Ankalgi, A.D., Agal, S.K., Ranawat, M.S., (2011) Int. J. Pharm. Technol., 3, pp. 118-123
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Download

Collections

Faculty Of Pharmacy Research Paper